{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:23:02Z","timestamp":1772893382993,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","award":["G-18-0022050"],"award-info":[{"award-number":["G-18-0022050"]}],"id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.cjca.2025.07.020","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:52:43Z","timestamp":1753141963000},"page":"2143-2154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Left Atrial Myopathy and Atrial Arrhythmia Recurrence After Pulmonary Vein Isolation in Patients With Minimal Left Atrial Low Voltage Areas"],"prefix":"10.1016","volume":"41","author":[{"given":"Sophia Z.","family":"Massin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Suszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filo","family":"Billia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.T.","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon M.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick R.","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Mak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9264-5073","authenticated-orcid":false,"given":"Vijay S.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2025.07.020_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/europace\/euaa009","article-title":"Atrial fibrosis as a dominant factor for the development of atrial fibrillation: facts and gaps","volume":"22","author":"Xintarakou","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.07.020_bib2","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/jce.13321","article-title":"Low-voltage areas detected by high-density electroanatomical mapping predict recurrence after ablation for paroxysmal atrial fibrillation","volume":"28","author":"Vlachos","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jacc.2004.10.035","article-title":"Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure","volume":"45","author":"Verma","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024521","article-title":"Atrial structural remodeling in patients with atrial fibrillation is a diffuse fibrotic process: evidence from high-density voltage mapping and atrial biopsy","volume":"11","author":"Yamaguchi","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cjca.2025.07.020_bib5","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.amjcard.2012.10.049","article-title":"Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse","volume":"111","author":"Cameli","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/srep40378","article-title":"Galectin-3 as a marker of interstitial atrial remodelling involved in atrial fibrillation","volume":"7","author":"Hern\u00e1ndez-Romero","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cjca.2025.07.020_bib7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.hrthm.2018.03.021","article-title":"Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: association with atrial fibrillation progression phenotypes","volume":"15","author":"B\u00fcttner","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.07.020_bib8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/europace\/euw335","article-title":"Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis","volume":"19","author":"Jiang","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.07.020_bib9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0735-1097(99)00263-6","article-title":"Noninvasive assessment of left atrial maximum dP\/dt by a combination of transmitral and pulmonary venous flow","volume":"34","author":"Nakatani","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/eurheartj\/ehi066","article-title":"Functional impact of rate irregularity in patients with heart failure and atrial fibrillation receiving cardiac resynchronisation therapy","volume":"26","author":"Melenovsky","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.07.020_bib11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/ejhf.645","article-title":"Global left atrial failure in heart failure","volume":"18","author":"Triposkiadis","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2025.07.020_bib12","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.hrthm.2016.05.028","article-title":"EHRA\/HRS\/APHRS\/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterisation, and clinical implication","volume":"14","author":"Goette","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.07.020_bib13","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jacep.2022.03.012","article-title":"Circumferential pulmonary vein isolation plus low-voltage area modification in persistent atrial fibrillation: the STABLE-SR-II trial","volume":"8","author":"Yang","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib14","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/jce.15013","article-title":"Easily available ECG and echocardiographic parameters for prediction of left atrial remodeling and atrial fibrillation recurrence after pulmonary vein isolation: a multicenter study","volume":"32","author":"Moreno-Weidmann","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/jce.14391","article-title":"Computed tomography\u2013derived left atrial volume index, sex, and age to predict the presence and the extent of left atrial low-voltage zones in patients with atrial fibrillation: the ZAQ score","volume":"31","author":"D\u2019Ambrosio","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib16","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/europace\/euab052","article-title":"Left atrial phasic transport function closely correlates with fibrotic and arrhythmogenic atrial tissue degeneration in atrial fibrillation patients: cardiac magnetic resonance feature tracking and voltage mapping","volume":"23","author":"Sch\u00f6nbauer","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.07.020_bib17","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.hrthm.2014.12.007","article-title":"Mechanical and substrate abnormalities of the left atrium assessed by 3-dimensional speckle-tracking echocardiography and electroanatomic mapping system in patients with paroxysmal atrial fibrillation","volume":"12","author":"Watanabe","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.07.020_bib18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ijcard.2018.07.048","article-title":"Extent and magnitude of low-voltage areas assessed by ultra-high-density electroanatomical mapping correlate with left atrial function","volume":"272","author":"Hohendanner","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib19","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/jce.14837","article-title":"Evaluation of left atrial remodeling by 2D-speckle-tracking echocardiography versus by high-density voltage mapping in patients with atrial fibrillation","volume":"32","author":"Laish-Farkash","year":"2021","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003163","article-title":"Association between left atrial stiffness index and atrial fibrillation recurrence in patients undergoing left atrial ablation","volume":"9","author":"Khurram","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib21","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.jacc.2011.05.061","article-title":"Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age","volume":"58","author":"Platonov","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib22","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/j.hrthm.2021.07.059","article-title":"Extracellular matrix remodeling precedes atrial fibrillation: results of the PREDICT-AF trial","volume":"18","author":"van den Berg","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.07.020_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007588","article-title":"Clinicopathological bird\u2019s-eye view of left atrial myocardial fibrosis in 121 patients with persistent atrial fibrillation","volume":"13","author":"Callegari","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib24","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2025.07.020_bib25","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1093\/europace\/euv045","article-title":"Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease","volume":"17","author":"Wu","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2025.07.020_bib26","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/eurheartj\/ehy815","article-title":"Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation","volume":"40","author":"Chua","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.07.020_bib27","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.hrthm.2018.06.025","article-title":"Association of fibrotic remodeling and cytokines\/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation","volume":"15","author":"Abe","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.cjca.2025.07.020_bib28","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.echo.2019.07.003","article-title":"Echocardiographic risk assessment to guide screening for atrial fibrillation","volume":"32","author":"Ramkumar","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.cjca.2025.07.020_bib29","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.amjcard.2012.12.021","article-title":"Clinical significance of the assessment of the systolic and diastolic myocardial function of the left atrium in patients with paroxysmal atrial fibrillation and low CHADS2 index treated with catheter ablation therapy","volume":"111","author":"Morris","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2025.07.020_bib30","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.07.020_bib31","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa2029980","article-title":"Cryoablation or drug therapy for initial treatment of atrial fibrillation","volume":"384","author":"Andrade","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.07.020_bib32","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2212540","article-title":"Progression of atrial fibrillation after cryoablation or drug therapy","volume":"388","author":"Andrade","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.07.020_bib33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/00000542-200109000-00023","article-title":"Desflurane, sevoflurane, and isoflurane affect left atrial active and passive mechanical properties and impair left atrial-left ventricular compling in vivo","volume":"95","author":"Gare","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cjca.2025.07.020_bib34","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1161\/01.CIR.0000091408.45747.04","article-title":"Reversal of atrial mechanical dysfunction after cardioversion of atrial fibrillation","volume":"108","author":"Sanders","year":"2003","journal-title":"Circulation"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25006336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25006336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:52:38Z","timestamp":1772819558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X25006336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0828282X25006336"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2025.07.020","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left Atrial Myopathy and Atrial Arrhythmia Recurrence After Pulmonary Vein Isolation in Patients With Minimal Left Atrial Low Voltage Areas","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}